Abstract
Essential hypertension (EH) is characterised by increased thrombotic tendency and impaired fibrinolytic activity. However, exercise-induced changes in coagulation and fibrinolysis have not yet been clarified. We aimed at determining thrombotic and fibrinolytic activity during exercise in patients with EH pre and post treatment with an Angiotensin II receptor blocker. Study 1 consisted of 30 untreated hypertensive (UH) and 15 normotensive (NT) individuals. The UH individuals who received treatment were included in study 2 and were followed up after a 3-month treatment period with valsartan. Thrombin–antithrombin (TAT) complexes and human plasminogen activator inhibitor-1 (PAI-1) were measured as markers of coagulation and fibrinolysis, respectively, at baseline, immediately after a treadmill exercise test and 30 min later. In UH, TAT and PAI-1 levels were significantly increased immediately after peak exercise and decreased 30 min later, as compared with baseline levels. At all time points, UH exhibited significantly higher TAT and PAI-1 levels compared with NT. No significant changes of TAT and PAI-1 levels were observed in NT and in patients post treatment. Acute high-intensity exercise results in impaired thrombotic and fibrinolytic response in untreated patients with EH. Angiotensin II receptor blockade with adequate blood pressure control greatly improves exercise-induced changes in coagulation and fibrinolysis in EH.
Similar content being viewed by others
References
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159–2219.
Trifiletti A, Barbera N, Pizzoleo MA, Lasco A, Lucifora S, Leone G et al. Haemostatic variables in arterial hypertension. Haemostasis 1995; 25 (5): 237–240.
Makris TK, Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J et al. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997; 88 (2): 99–107.
Yang P, Liu YF, Yang L, Wei Q, Zeng H . Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension. Clin Cardiol 2010; 33 (6): E81–E86.
Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 2006; 26 (12): 2793–2799.
Vaughan DE . PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3 (8): 1879–1883.
Papadopoulos D, Mourouzis I, Kotrotsou A, Papazachou U, Sanidas E, Tsioufis K et al. Hemostasis parameters disturbances in healthy individuals with prehypertension. Clin Exp Hypertens 2012; 34 (6): 385–388.
Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49 (3): 432–438.
von Kanel R, Hong S, Pung MA, Mills PJ . Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise. Am J Hypertens 2007; 20 (6): 670–675.
Lekakis J, Triantafyllidi H, Galea V, Koutroumbi M, Theodoridis T, Komporozos C et al. The immediate effect of aerobic exercise on haemostatic parameters in patients with recently diagnosed mild to moderate essential hypertension. J Thromb Thrombolysis 2008; 25 (2): 179–184.
DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF . Fibrinolytic responses to acute physical activity in older hypertensive men. J Appl Physiol (1985) 1997; 82 (6): 1765–1770.
Liakos CI, Vyssoulis GP, Michaelides AP, Chatzistamatiou EI, Theodosiades G, Toutouza MG et al. The effects of angiotensin receptor blockers vs calcium channel blockers on the acute exercise-induced inflammatory and thrombotic response. Hypertens Res 2012; 35 (12): 1193–1200.
Gkaliagkousi E, Gavriilaki E, Yiannaki E, Markala D, Papadopoulos N, Triantafyllou A et al. Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker. Am J Hypertens, (e-pub ahead of print 23 August 2013).
Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF et al. ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 1997; 96 (1): 345–354.
Szymanski LM, Pate RR . Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men. Med Sci Sports Exerc 1994; 26 (9): 1102–1108.
Galea V, Triantafyllidi H, Theodoridis T, Koutroumbi M, Christopoulou-Cokkinou V, Kremastinos D et al. Long-term treatment with ramipril favourably modifies the haemostatic response to acute submaximal exercise in hypertensives. J Renin Angiotensin Aldosterone Syst 2012; 14: 322–329.
Liakos CI, Michaelides AP, Vyssoulis GP, Chatzistamatiou EI, Dilaveris PE, Markou MI et al. The antihypertensive treatment effect on left ventricular diastolic function is reflected in exercise electrocardiogram. J Electrocardiol 2012; 45 (1): 28–35.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Gavriilaki, E., Gkaliagkousi, E., Nikolaidou, B. et al. Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: The effect of treatment with an angiotensin II receptor blocker. J Hum Hypertens 28, 606–609 (2014). https://doi.org/10.1038/jhh.2014.18
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2014.18
- Springer Nature Limited
This article is cited by
-
Tracking Biomarker Responses to Exercise in Hypertension
Current Hypertension Reports (2023)
-
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise
American Journal of Cardiovascular Drugs (2019)